Trevor Hambley is Emeritus Professor of Chemistry in the School of Chemistry, Faculty of Science at the University of Sydney. He earned his BSc (Hons I) from the University of Western Australia and PhD from the University of Adelaide. Throughout his career, he has held positions at the Australian National University, Emory University, Birkbeck College University of London, and the University of Sydney. At Sydney, he advanced to Full Professor, served as Head of the School of Chemistry from 2013 to 2016, and as Dean of the Faculty of Science.

Hambley's research centers on medicinal inorganic chemistry, with key interests in bioinorganic chemistry, crystallography, and molecular mechanics applied to coordination complexes. He has pioneered insights into how metal-ligand bond lengths and ligand conformations influence chemical and physical properties. His multidisciplinary studies on metal anti-cancer drugs integrate chemical synthesis, biochemical assays, and cell biology to design superior platinum-based therapeutics, understand cisplatin mechanisms, develop hypoxia-selective cobalt complexes, and explore metal-based anti-inflammatory agents. He has produced three books, including Molecular Modeling of Inorganic Compounds (2009), thirteen reviews—such as those on platinum drug structure-activity relationships and Pt-DNA modeling—and over 400 refereed journal articles, amassing 682 publications and more than 21,000 citations. Hambley received the Edgeworth David Medal for early-career contributions to science, the University of Sydney Supervisor of the Year award in 1997, and Excellence in Postgraduate Supervision award in 1998. A Fellow of the Australian Academy of Science since 2011, he was President of the Society for Biological Inorganic Chemistry, contributing significantly to the field through leadership and editorial roles.

Professional Email: trevor.hambley@sydney.edu.au